Bayer has paid over $400 million in Yasmin lawsuit settlements, drugmaker says

by John Chapman

Drugmaker Bayer AG announced that it has paid over $402 million to settle lawsuit filed by women who suffered blood clots or other injuries from using the company’s Yasmin birth control pills. Speaking in a newsletter that was sent to stockholders, the company stated that it had reached settlements in almost 1,900 Yasmin lawsuits filed by former patients.

Bayer also announced that it had set aside more than $600 million in reserves this quarter to resolve additional lawsuits over Yasmin and Yaz that have been filed against the company. Bayer had previously announced that it was facing more than 12,000 Yasmin and Yaz lawsuits, with more expected to be filed in the future.

Both Yaz and Yasmin contain a hormone known as drospirenone, which has been shown to increase the risk of blood clots compared to other types of birth control. According to multiple studies, women taking Yaz or Yasmin may be up to three times more likely to suffer blood clots than users of another birth control brand. These blood clots could also increase the risk of other side effects, including deep vein thrombosis, pulmonary embolism, or stroke. In April 2012, the Food and Drug Administration ordered Bayer to add stronger warnings to the labels of Yaz and Yasmin to alert women about the blood clot risks associated with the two drugs.

Experts believe that Bayer may eventually have to pay as much as $2.5 billion in Yasmin and Yaz settlements to resolve the lawsuits facing the company. In addition to lawsuits that have been filed by women who suffered blood clots after using Yaz or Yasmin, Bayer is also facing allegations that the birth control drugs caused gallbladder injuries in some users.

If you or a loved one suffered blood clots or other complications after Yaz or Yasmin, you may be entitled to compensation for your injuries. To find out if you may have a case, contact the lawyers at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001, or by filling out our free online case evaluation form.